関連する実験動画
Updated: Jan 18, 2026

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus MRSA
Published on: February 9, 2011
小児科における川崎病
Sabrina Bressieux-Degueldre1, Katerina Theodoropoulou2, Alain Lefèvre-Utile3
1Unité de cardiologie pédiatrique, Service de pédiatrie, Département femme-mère-enfant, Centre hospitalier universitaire vaudois, 1011 Lausanne.
Abstract:
Kawasaki disease is an acute vasculitis affecting mostly children under 5 years of age. If left untreated, patients are at risk of 25% coronary involvement. European and NorthAmerican guidelines have recently been updated. Diagnostic is based on the association of skin, mucosal and lymphoid symptom and can be made up to 4 days after fever onset in complete forms. High-risk coronary criteria are used to guide the early treatment. Progress in immunological and cardiac treatments enhances refractory disease and coronary complication prognosis. This article incorporates recent proposals while focusing on key practices in french-speaking Switzerland.
関連する概念動画
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Pediatric Patients: Drug Distribution
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Rheumatic Heart Disease I: Introduction
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

